Clinical impact of aneuploidy on gastric cancer patients

Clinical and Translational Oncology

Volumn 11, Issue 8, 2009, Pages 493-498

  Sánchez Pérez, Isabel ^a   Alonso, Pilar García ^b   Iniesta, Cristóbal Belda ^c  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cell cycle; Chromosome mis segregation; Gastric cancer; Mitotic checkpoint; Prognosis

Indexed keywords

ANEUPLOIDY; ANIMAL; CENTROSOME; GENETICS; HUMAN; METABOLISM; MITOSIS SPINDLE; PATHOLOGY; REVIEW; STOMACH TUMOR;

ANEUPLOIDY; ANIMALS; CENTROSOME; HUMANS; MITOTIC SPINDLE APPARATUS; STOMACH NEOPLASMS;

EID: 74049135736     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-009-0393-z     Document Type: Article

References (63)

1. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362:305-315
2. Correa P, Piazuelo MB, Camargo MC (2004) The future of gastric cancer prevention. Gastric Cancer 7:9-16
3. Correa P, Haenszel W, Cuello C et al (1975) A model for gastric cancer epidemiology. Lancet 2:58-60
4. Cahill DP, Lengauer C, Yu J et al (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392:300-303
5. Weaver BA, Cleveland DW (2006) Does aneuploidy cause cancer? Curr Opin Cell Biol 18:658-667
6. Yonemura Y, Ooyama S, Sugiyama K et al (1990) Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma. Cancer Res 50:509-514
7. Rugge M, Sonego F, Panozzo M et al (1994) Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis. Cancer 73:1127-1133
8. Sakusabe M, Kodama M, Sato Y et al (1996) Clinical significance of DNA ploidy pattern in stage III gastric cancer. World J Surg 20:27-31
9. Victorzon M, Lundin J, Haglund C et al (1996) A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy: A multivariate analysis. Int J Cancer 67:190-193
10. Victorzon M, Roberts PJ, Haglund C et al (1996) Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 53:182-191
11. Abad M, Ciudad J, Rincon MR et al (1998) DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer. Anal Cell Pathol 16:223-231
12. Setala LP, Nordling S, Kosma VM et al (1997) Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer. Anal Quant Cytol Histol 19:524-532
13. Danesi DT, Spano M, Fabiano A et al (2000) Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients. Cytometry 42:27-34
14. Ohyama S, Yonemura Y, Miyazaki I (1992) Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application. Cancer 69:314-321
15. Lee KH, Lee JS, Lee JH et al (1999) Prognostic value of DNA flow cytometry in stomach cancer: A 5-year prospective study. Br J Cancer 79:1727-1735
16. Esteban F, de Vega DS, Garcia R et al (1999) DNA content by flow cytometry in gastric carcinoma: Pathology, ploidy and prognosis. Hepatogastroenterology 46:2039-2043
17. Russo A, Bazan V, Migliavacca M et al (2001) DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study. Cancer 92:294-302
18. Takeno SS, Leal MF, Lisboa LC et al (2009) Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization. Cancer Genet Cytogenet 190:1-7
19. Doak SH, Jenkins GJ, Parry EM et al (2003) Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus. Gut 52:623-628
20. Williams L, Jenkins GJ, Doak SH et al (2005) Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: The potential involvement of Helicobacter pylori. Br J Cancer 92:1759-1766
21. Pihan GA, Wallace J, Zhou Y et al (2003) Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63:1398-1404
22. Nigg EA (2007) Centrosome duplication: Of rules and licenses. Trends Cell Biol 17:215-221
23. Bischoff JR, Anderson L, Zhu Y et al (1998) A homologue of Drosophila aurora kinase is oncogenic and amplifi ed in human colorectal cancers. EMBO J 17:3052-3065
24. Zhou H, Kuang J, Zhong L et al (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20:189-193
25. Anand S, Penrhyn-Lowe S, Venkitaraman AR (2003) AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3:51-62
26. Azimzadeh J, Bornens M (2007) Structure and duplication of the centrosome. J Cell Sci 120:2139-2142
27. Jang YJ, Kim YS, Kim WH (2006) Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas. Int J Oncol 29:589-594
28. Cleveland DW, Mao Y, Sullivan KF (2003) Centromeres and kinetochores: From epigenetics to mitotic checkpoint signaling. Cell 112:407-421
29. Abrieu A, Magnaghi-Jaulin L, Kahana JA et al (2001) Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell 106:83-93
30. Li Y, Benezra R (1996) Identification of a human mitotic checkpoint gene: HsMAD2. Science 274:246-248
31. Taylor SS, Ha E, McKeon F (1998) The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase. J Cell Biol 142:1-11
32. Peters JM (2006) The anaphase promoting complex/cyclosome: A machine designed to destroy. Nat Rev Mol Cell Biol 7:644-656
33. Kops GJ, Weaver BA, Cleveland DW (2005) On the road to cancer: Aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5:773-785
34. Hanks S, Coleman K, Reid S et al (2004) Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36:1159-1161
35. Matsuura S, Matsumoto Y, Morishima K et al (2006) Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am J Med Genet A 140:358-367
36. Bohers E, Sarafan-Vasseur N, Drouet A et al (2008) Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidy. Hum Genet 124:473-478
37. Kim HS, Park KH, Kim SA et al (2005) Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint. Mutat Res 578:187-201
38. Nakagawa H, Yokozaki H, Oue N et al (2002) No mutations of the Bub1 gene in human gastric and oral cancer cell lines. Oncol Rep 9:1229-1232
39. Babu JR, Jeganathan KB, Baker DJ et al (2003) Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 160:341-353
40. Dai W, Wang Q, Liu T et al (2004) Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsuffi ciency. Cancer Res 64:440-445
41. Michel LS, Liberal V, Chatterjee A et al (2001) MAD2 haplo-insuffi ciency causes premature anaphase and chromosome instability in mammalian cells. Nature 409:355-359
42. Iwanaga Y, Chi YH, Miyazato A et al (2007) Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res 67:160-166
43. Grabsch H, Takeno S, Parsons WJ et al (2003) Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer: Association with tumour cell proliferation. J Pathol 200:16-22
44. Cimini D, Howell B, Maddox P et al (2001) Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153:517-527
45. Cimini D, Wan X, Hirel CB et al (2006) Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr Biol 16:1711-1718
46. Knowlton AL, Lan W, Stukenberg PT (2006) Aurora B is enriched at merotelic attachment sites, where it regulates MCAK. Curr Biol 16:1705-1710
47. Cimini D, Fioravanti D, Salmon ED et al (2002) Merotelic kinetochore orientation versus chromosome mono-orientation in the origin of lagging chromosomes in human primary cells. J Cell Sci 115:507-515
48. Kollareddy M, Dzubak P, Zheleva D et al (2008) Aurora kinases: Structure, functions and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:27-33
49. Macarulla T, Ramos FJ, Tabernero J (2008) Aurora kinase family: A new target for anticancer drug. Recent Pat Anticancer Drug Discov 3:114-122
50. Cheung CH, Coumar MS, Hsieh HP et al (2009) Aurora kinase inhibitors in preclinical and clinical testing. Expert Opin Investig Drugs 18:379-398
51. Nakamura Y, Tanaka F, Haraguchi N et al (2007) Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 97:543-549
52. Shimo A, Tanikawa C, Nishidate T et al (2008) Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci 99:62-70
53. Sandall S, Severin F, McLeod IX et al (2006) A Bir1-Sli15 complex connects centromeres to microtubules and is required to sense kinetochore tension. Cell 127:1179-1191
54. Wang TT, Qian XP, Liu BR (2007) Survivin: Potential role in diagnosis, prognosis and targeted therapy of gastric cancer. World J Gastroenterol 13:2784-2790
55. Wang Y, Zhou X, Zhu H et al (2005) Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway. Oncogene 24:6637-6645
56. Nishigaki R, Osaki M, Hiratsuka M et al (2005) Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 5:3205-3213
57. Williams L, Somasekar A, Davies DJ et al (2009) Aneuploidy involving chromosome 1 may be an early predictive marker of intestinal type gastric cancer. Mutat Res [Epub ahead of print]
58. Yang YC, Wang SW, Wu IC et al (2009) A tumorigenic homeobox (HOX) gene expressing human gastric cell line derived from putative gastric stem cell. Eur J Gastroenterol Hepatol [Epub ahead of print]
59. Liang Z, Zeng X, Gao J et al (2008) Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients. BMC Cancer 8:363
60. van Dekken H, van Marion R, Vissers KJ et al (2008) Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifi es cyclin-dependent kinase 6 at both genomic and protein expression levels. Genes Chromosomes Cancer 47:649-656
61. Calcagno DQ, Guimaraes AC, Leal MF et al (2009) MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res 29:2479-2483
62. Vauhkonen H, Vauhkonen M, Sipponen P et al (2007) Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas. Cytogenet Genome Res 119:39-45
63. Yang SH, Seo MY, Jeong HJ et al (2005) Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res 11:612-620